Pharmaceutical firm Mylan will pay up to $335M over opioid drug crisis
Briefly

New York Attorney General Letitia James announced a multistate settlement with Viatris, resulting in $335 million to combat the opioid crisis. The settlement comes after allegations that Mylan, now part of Viatris, had prior knowledge that its opioids, especially fentanyl patches, were more vulnerable to abuse, yet marketed them as safer. This deceptive promotion contributed to overprescribing and illegal distribution of opioids. While the company agreed to the settlement, it did not admit wrongdoing. The funds will be distributed to participating states over the next nine years.
When drug companies put profits over people, innocent patients can get sucked into deadly cycles of addiction and overdoses.
Mylan deceptively promoted its products as less prone to abuse, despite knowing for years that many of those products were actually more vulnerable to abuse.
Read at Brooklyn Eagle
[
|
]